Ex parte GAST - Page 2



                  Appeal No.  2001-1819                                                           Page 2                   
                  Application No.  08/886,072                                                                              

                  wherein the same dosage of the progestin and estrogen combination is                                     
                  administered in each of the 23-25 days.                                                                  

                         The references relied upon by the examiner are:                                                   

                         Bennink                     5,418,228                   May 23, 1995                            
                         Barcomb                     5,547,948                   Aug. 20, 1996                           
                         Spona et al. (Spona)         5,583,129                   Dec. 10, 1996                           
                         Oettel et al. (Oettel)       5,633,242                   May. 27, 1997                           
                         Upton                       0,253,607                   Jan. 20, 1988                           
                         (European Patent Application)                                                                     

                                               GROUND OF REJECTION                                                         

                         Claims 1-17 and 23-29 stand rejected under 35 U.S.C. § 103 as being                               

                  unpatentable over Bennink, Spona2 and Upton in view of Oettel and Barcomb.                               

                         We reverse.                                                                                       

                                                      DISCUSSION                                                           

                         As set forth in In re Dow Chemical Co. 837 F.2d 469, 473, 5 USPQ2d 1529,                          

                  1531 (Fed. Cir. 1988), “[t]he consistent criterion for determination of obviousness is                   

                  whether the prior art would have suggested to one of ordinary skill in the art that this                 

                  process should be carried out and would have a reasonable likelihood of success,                         

                  viewed in the light of the prior art.”                                                                   

                         On this record, the examiner finds (Answer, page 3) that Bennink, Spona and                       

                  Upton teach contraceptive methods, compositions and kits “employing                                      


                                                                                                                           
                  2 We note that Spona, et al., United States Patent No. 5,583,129, relied upon by the examiner in         
                  the Answer, is not the same reference relied upon in the Final Rejection, which was Spona, et al.,       
                  WO 95/17194 (June 29, 1995).  The examiner provides no explaination for changing references.  We         
                  note, however, that the change in references appears to result in a new ground of rejection.  To the     
                  extent the examiner has “switched horses” in the Answer and presents a different ground of               
                  rejection than that developed during prosecution, we note, as set forth in 37 C.F.R. § 1.193(a)(2)       
                  (1998), “[a]n examiner’s answer must not include a new ground of rejection….”  We emphasize that         
                  the Answer was mailed after the effective date of this rule, and therefore the examiner erred in         
                  introducing a new ground of rejection in the Answer.  Nevertheless, given our disposition, we find       
                  this error harmless.                                                                                     







Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007